Mitoxantrone ± Cetuximab 2nd Line Androgen Independent Prostate Cancer (AIPC)
Public ClinicalTrials.gov record NCT00661492. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized Phase II Study of Mitoxantrone vs. Mitoxantrone With Cetuximab in Metastatic Androgen Independent Prostate Cancer (AIPC) Previously Treated With Docetaxel-based Chemotherapy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To determine the time to progression produced by the combination of Novantrone (mitoxantrone) and Erbitux (cetuximab) versus Novantrone alone in metastatic AIPC patients previously treated with docetaxel-based chemotherapy. TTP is defined as time from the start of treatment date to the date the patient is first recorded as having disease progression, even in patients who discontinue study treatment early due to toxicity.
Study identification
- NCT ID
- NCT00661492
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 115 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 30, 2008
- Primary completion
- Feb 28, 2011
- Completion
- May 31, 2011
- Last update posted
- Dec 8, 2016
2008 – 2011
United States locations
- U.S. sites
- 55
- U.S. states
- 18
- U.S. cities
- 52
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Hematology Oncology Associates | Phoenix | Arizona | 85012 | — |
| Northern AZ Hematology & Oncology Assoc | Sedona | Arizona | 86336 | — |
| Rocky Mountain Cancer Center-Midtown | Denver | Colorado | 80218 | — |
| Melbourne Internal Medicine Associates | Melbourne | Florida | 32901 | — |
| Florida Cancer Institute - New Hope | New Port Richey | Florida | 34655 | — |
| Ocala Oncology Center | Ocala | Florida | 34474 | — |
| Cancer Centers of Florida, P.A. | Ocoee | Florida | 34761 | — |
| Cancer Care & Hematology Specialists of Chicagoland | Niles | Illinois | 60714 | — |
| Central Indiana Cancer Centers | Indianapolis | Indiana | 46277 | — |
| Hope Center | Terre Haute | Indiana | 47802 | — |
| Minnesota Oncology Hematology, P.A. | Minneapolis | Minnesota | 55404 | — |
| Missouri Cancer Associates | Columbia | Missouri | 65201 | — |
| St. Joseph Oncology, Inc. | Saint Joseph | Missouri | 64507 | — |
| Comprehensive Cancer Centers of Nevada | Las Vegas | Nevada | 89169 | — |
| NH Oncology-Hematology PA | Hooksett | New Hampshire | 03106 | — |
| Hematology-Oncology Associates of NNJ, P | Morristown | New Jersey | 07960 | — |
| Albany Medical Cancer Center | Albany | New York | 12208 | — |
| Interlakes Oncology Hematology, PC | Rochester | New York | 14623 | — |
| Cancer Centers of North Carolina | Raleigh | North Carolina | 27607 | — |
| Greater Dayton Cancer Center | Kettering | Ohio | 45409 | — |
| Willamette Valley Cancer Center | Eugene | Oregon | 97401 | — |
| Oregon Health & Science University | Portland | Oregon | 97239 | — |
| Cancer Centers of the Carolinas | Greenville | South Carolina | 29605 | — |
| Texas Oncology, P.A. -Amarillo | Amarillo | Texas | 79106 | — |
| Texas Oncology, P.A. | Arlington | Texas | 76012 | — |
| Texas Oncology - Central Austin Cancer Center | Austin | Texas | 78731 | — |
| Mamie McFaddin Ward Cancer Center | Beaumont | Texas | 77702 | — |
| Texas Cancer Center at Medical City | Dallas | Texas | 75230 | — |
| Texas Oncology, P.A. | Dallas | Texas | 75231 | — |
| Methodist Charlton Cancer Ctr. | Dallas | Texas | 75237 | — |
| Texas Oncology, P.A. | Dallas | Texas | 75246 | — |
| Texas Cancer Center | Denton | Texas | 76210 | — |
| El Paso Cancer Treatment Ctr | El Paso | Texas | 79915 | — |
| Texas Oncology, P.A. | Fort Worth | Texas | 76104 | — |
| Texas Oncology, P.A | Garland | Texas | 75042 | — |
| Longview Cancer Center | Longview | Texas | 75601 | — |
| South Texas Cancer Center - McAllen | McAllen | Texas | 78503 | — |
| Texas Cancer Center of Mesquite | Mesquite | Texas | 75150 | — |
| Allison Cancer Center | Midland | Texas | 79701 | — |
| Texas Oncology - Odessa | Odessa | Texas | 79761 | — |
| Paris Regional Cancer Center | Paris | Texas | 75460 | — |
| Texas Cancer Center - Sherman | Sherman | Texas | 75090 | — |
| Texas Oncology Cancer Center-Sugar Land | Sugar Land | Texas | 77479 | — |
| Tyler Cancer Center | Tyler | Texas | 75702 | — |
| Texas Oncology, P.A. | Webster | Texas | 77598 | — |
| Fairfax Northern VA Hem-Onc PC | Fairfax | Virginia | 22031 | — |
| Virginia Oncology Associates | Norfolk | Virginia | 23502 | — |
| Onc and Hem Associates of SW VA, Inc. | Salem | Virginia | 24153 | — |
| Highline Medical Oncology | Burien | Washington | 98166 | — |
| Puget Sound Cancer Center-Edmonds | Edmonds | Washington | 98026 | — |
| Columbia Basin Hematology and Oncology | Kennewick | Washington | 99336 | — |
| Puget Sound Cancer Center-Seattle | Seattle | Washington | 98133 | — |
| Cancer Care Northwest-South | Spokane | Washington | 99202 | — |
| Northwest Cancer Specialists-Vancouver | Vancouver | Washington | 98684 | — |
| Yakima Valley Mem Hosp/North Star Lodge | Yakima | Washington | 98902 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00661492, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 8, 2016 · Synced Sep 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00661492 live on ClinicalTrials.gov.